Kaneh’s products are patent pending, with a Blanket Provisional Utility Paten. CN3 is one formulary and there are many others which will also be submitted, locking up the hemp seed oil category
Kaneh enters the cannabis market with the holy grail in the industry; a pending patent on cannabis seed oil compositions, with uses aimed at ameliorating human health.
Patent claims are wide, and include treating inflammation, vascular and heart health, as well as commonly seen behavioral issues.
CN3 formulas, comprised 100% of cannabis seed oil, are devoid of cannabinoids, which are federally restricted as they are the active constituents in cannabis.
100 Million Americans live with chronic pain. Why treat the symptom, if you can treat the problem? The common thread among all illnesses is inflammation due to dietary imbalances.
The active ingredient in CN3 is Cannabis Omega-3, an essential fatty acid (EFA) needed for human health, known for strengthening the immune system and reducing inflammation throughout the body. Our products are also 100% legal in the U.S.
A variety of compositions are available, as CN3 can either be used within products or as a stand-alone.
The CN3 formula encompasses hemp seed oil for beneficial health uses; whether internally digested, inhaled, or topically on the skin as a dermatologic product or in animal care products.
Competition is scarce, inclusive of Omega-3 fish oils as well as Cannabis-derived CBD oil
This is a new product and set to take over the Cannabis and Health industry, to this point all Finances Bootstrapped.
*Needs Brand & Product Development which is main reason for funding needs
*New Category, no consumer recognition